Recently, there has been a significant number of claims sold or purchased by investment advisories and banks such as Gateway Investment Advisers LLC, Cetera Investment Advisers, Capital Investment Advisors LLC, and Wesbanco Bank Inc. among others related to Celanese Corporation. Celanese stocks' performance has been cited as underperforming the market, however, they experienced a surge over six months. Q2 earnings fell short of estimates, drawing concerns over leverage risks despite margin expansion. Wells Fargo & Company and Royal Bank of Canada lowered price targets, indicating increased pressure. Nevertheless, robust cash flow and deleveraging have been reported despite market challenges. Celanese Corporation declared force majeure due to supply disruptions, lifting the same later for Western Hemisphere Acetic Acid and VAM. The Corporation also intends to distribute a quarterly dividend of $0.70 per share. Despite missed earnings estimates in Q4, Celanese's second quarter earnings reports are anticipated with interest. The anticipation builds on the back of the company affirming its dividend and registering milestones in the acetyl chain business. Although the company's 2024 earnings forecast was reduced leading to a drop in shares, the potential for the stocks rebounding isn't ruled out.
Celanese Corporation CE News Analytics from Tue, 20 Feb 2024 08:00:00 GMT to Sun, 11 Aug 2024 15:36:01 GMT - Rating -1 - Innovation 3 - Information 5 - Rumor 2
